INMUNOENSAYO PARA LA DETERMINACIÓN DE ANTICUERPOS IGG CONTRA SM
Mexico·Clase I·III. Agentes de diagnóstico·INSUMOS PARA LA
SALUD, S.A. DE C.V.·Registered October 21, 2022- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. Agentes de diagnóstico
- Product Type (English)
- III. Agentes de diagnóstico
- Trade Name (Spanish)
- MAGLUMI® ANTI-SM IGG (CLIA)
- Trade Name (English)
- MAGLUMI® ANTI-SM IGG (CLIA)
- Analysis ID
- 1140R2022 SSA
- Registration Date
- October 21, 2022
- Name (Spanish)
- INSUMOS PARA LA SALUD, S.A. DE C.V.
- Name (English)
- INSUMOS PARA LA SALUD, S.A. DE C.V.
Access comprehensive regulatory information for INMUNOENSAYO PARA LA DETERMINACIÓN DE ANTICUERPOS IGG CONTRA SM (INMUNOENSAYO PARA LA DETERMINACIÓN DE ANTICUERPOS IGG CONTRA SM) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1140R2022 SSA and manufactured by INSUMOS PARA LA SALUD, S.A. DE C.V.. The device was registered on October 21, 2022.
This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.